How Can Nanotechnology Enhance Immune Checkpoint Inhibitors?
Nanotechnology can significantly enhance the efficacy of immune checkpoint inhibitors by improving drug delivery, increasing drug stability, and reducing side effects. Nanocarriers such as lipid nanoparticles, polymeric nanoparticles, and inorganic nanoparticles can be designed to deliver immune checkpoint inhibitors directly to the tumor site. This targeted delivery ensures higher concentrations of the drug reach the tumor while minimizing exposure to healthy tissues.
